Showing 1 to 10 of 2,370
Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
---|---|---|---|---|---|---|
Melphalan flufenamide with dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | Reference number:TA968 | TA00968 | Published:25 April 2024 | 20240425 | Last updated:25 April 2024 | 20240425 |
Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal) | Reference number:TA966 | TA00966 | Published:24 April 2024 | 20240424 | Last updated:24 April 2024 | 20240424 |
Lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema | Reference number:IPG785 | IPG00785 | Published:16 April 2024 | 20240416 | Last updated:16 April 2024 | 20240416 |
Endometriosis: diagnosis and management | Reference number:NG73 | NG00073 | Published:06 September 2017 | 20170906 | Last updated:16 April 2024 | 20240416 |
Cabozantinib with nivolumab for untreated advanced renal cell carcinoma | Reference number:TA964 | TA00964 | Published:10 April 2024 | 20240410 | Last updated:10 April 2024 | 20240410 |
Twin and triplet pregnancy | Reference number:NG137 | NG00137 | Published:04 September 2019 | 20190904 | Last updated:09 April 2024 | 20240409 |
Kurin Lock for blood culture collection | Reference number:MTG77 | MTG00077 | Published:03 April 2024 | 20240403 | Last updated:03 April 2024 | 20240403 |
GaitSmart rehabilitation exercise programme for gait and mobility issues | Reference number:MTG78 | MTG00078 | Published:03 April 2024 | 20240403 | Last updated:03 April 2024 | 20240403 |
Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency | Reference number:TA963 | TA00963 | Published:03 April 2024 | 20240403 | Last updated:03 April 2024 | 20240403 |
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer | Reference number:IPG784 | IPG00784 | Published:02 April 2024 | 20240402 | Last updated:02 April 2024 | 20240402 |